This work demonstrates the production of β-glucans from basidiomycete strains using agro-industrial wastes, indicating potential for waste valorization.
A huge amount of waste is produced annually by the food processing industry which must be valorized into high-value products. Therefore, the aim of this work involves the use of such wastes for production of β-glucans from medicinal basidiomycete strains which are powerful biological response modifiers in several clinical disorders. The production of β-glucans from basidiomycete strains in submerged fermentation was monitored by using monoclonal antibodies of the IgG and IgM classes as well as by Congo red assay in the presence of several agro-industrial waste products such as milk permeate, waste coffee grounds, orange peels and rice husks. Subsequently, these β-glucans were purified by using gel filtration and ion-exchange chromatography. FTIR analysis of several β-glucans was carried out to investigate their structural properties. The adsorption of β-glucans on microtiter plates was dependent on the temperature as well as on the time period of immobilization for ELISA. These mAbs can be used in a competitive ELISA for detection and quantification of β-glucans from basidiomycete mushrooms.
No takes yet. Share an insight, caveat, or question.
Amin Karmali (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: